GeneDx Holdings
58 hedge funds and large institutions have $83.8M invested in GeneDx Holdings in 2023 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 22 increasing their positions, 18 reducing their positions, and 39 closing their positions.
607% more call options, than puts
Call options by funds: $3.6M | Put options by funds: $510K
53.14% more ownership
Funds ownership: 1.79% → 54.93% (+53%)
22% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 18
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
29% less funds holding
Funds holding: 82 → 58 (-24)
51% less capital invested
Capital invested by funds: $172M → $83.8M (-$88M)
62% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 39
Top Buyers
| 1 |
CM
Corvex Management
New York
|
+$5.36M |
| 2 |
Millennium Management
New York
|
+$1.79M |
| 3 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$1.33M |
| 4 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$778K |
| 5 |
RC
RBF Capital
San Francisco,
California
|
+$554K |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$3.79M |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$3.56M |
| 3 |
BlackRock
New York
|
-$3.32M |
| 4 |
ACM
Altium Capital Management
New York
|
-$1.67M |
| 5 |
NM
Newtyn Management
New York
|
-$622K |
WGS Hedge Fund Activity: Q2 2023 in Review
58 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings (WGS) for Q2 2023, worth a combined $83.8M — down 51% from $172M a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of WGS and 15 opened new positions — a net loss of 24 holders — while 18 trimmed existing stakes and 22 added.
The largest buyer was Corvex Management, adding an estimated $5.36M. The largest seller was Deerfield Management, cutting an estimated $3.79M.
- 58 institutional investors held GeneDx Holdings (WGS) as of Q2 2023, down from 82 in Q1 2023.
- Funds reported $83.8M of GeneDx Holdings stock for Q2 2023, down 51% quarter-over-quarter.
- 15 funds opened new GeneDx Holdings positions in Q2 2023 and 39 closed out, a net change of -24 holders.
- The largest GeneDx Holdings buyer in Q2 2023 was Corvex Management, an estimated $5.36M added.
- The largest GeneDx Holdings seller in Q2 2023 was Deerfield Management, an estimated $3.79M sold.
Based on aggregated 13F filings for Q2 2023.